The Presence of Nitrosamines and Nitrosamine Drug-Related Substances in Pharmaceutical Products: An Overview of Regulatory Concerns, Analytical Methodologies, and Control Strategies

药品 医学 亚硝胺 活性成分 食品药品监督管理局 药物 生化工程 风险分析(工程) 毒理 药理学 致癌物 有机化学 化学 生物 工程类
作者
Neha M. Dhansekar,Pratiksha D. Rale,yogesh Ghalsasi
出处
期刊:Current Drug Safety [Bentham Science Publishers]
卷期号:20 (4): 404-414 被引量:7
标识
DOI:10.2174/0115748863324951241028050225
摘要

The presence of N-nitrosamine impurities in pharmaceutical products is well known. In 2019, it resulted in drug recall by the Food and Drug Administration (FDA). Soon, several groups identified the presence of many N-nitrosamines (NAs) in various Active Pharmaceutical Ingredients (APIs) and drug formulations worldwide. Moreover, in the last two years, another type of NAs was identified and detected in several pharmaceutical products. These are easily formed from the parent drug molecule and are known as Nitrosamine drug-related substances (NDSRIs). The amine group plays a major and unique role in the synthesis of many drug molecules, and hence, it is practically impossible to eliminate the presence of NAs and NDSRIs from drug products. The risk assessment of the health hazard to the patient was done, and the FDA has set the maximum daily acceptable intake (AI) at 18 ng/day for NAs. This limit poses a significant challenge in isolating, identifying and quantifying NAs and NDSRIs in APIs and formulations. For small, simple NAs, a lot of toxicological information and carcinogenetic data is available; however, for NDSRIs, such data is practically absent. This review article attempts to gather the toxicological data for a few NAs and NDSRIs and tries to assess the genotoxicity potential of some NDSRIs. The possible sources of NAs and NDSRIs, including synthetic methodology and processes, impurities associated with intermediates or raw materials, stability of the API, packaging materials, imprinting inks, and excipients, are also discussed. A summary of different analytical techniques used for the detection of these NAs and NDSRIs in different pharmaceutical products has also been included. Finally, various strategies employed for the minimization of these impurities along with additional control strategies to mitigate NAs and NDSRIs below acceptable limits, have also been discussed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我是老大的应助被帮帮我把采纳,获得10
刚刚
绘海发布了新的文献求助10
刚刚
eay发布了新的文献求助10
1秒前
Maestro_S的应助被Lazyazy_采纳,获得10
1秒前
qducly2026的应助被徐xx采纳,获得30
1秒前
2秒前
虚掩的门发布了新的文献求助30
2秒前
2秒前
春花奶的应助被wakaka采纳,获得10
2秒前
114514发布了新的文献求助10
3秒前
SciGPT的应助被Sun采纳,获得10
3秒前
Cpp完成签到,获得积分10
4秒前
4秒前
zhu完成签到,获得积分20
4秒前
天天快乐的应助被黑粉头头采纳,获得10
5秒前
无极微光的应助被佟春龙采纳,获得20
5秒前
朴素的懿轩完成签到,获得积分10
5秒前
简单书芹发布了新的文献求助10
6秒前
7秒前
7秒前
7秒前
丘比特的应助被李洪卓采纳,获得10
7秒前
兰金完成签到,获得积分10
8秒前
8秒前
leemark发布了新的文献求助10
9秒前
10秒前
10秒前
Lee完成签到,获得积分20
11秒前
打雷不下雨完成签到 ,获得积分10
11秒前
聪明威发布了新的文献求助10
12秒前
12秒前
ysw979发布了新的文献求助10
12秒前
赘婿的应助被114514采纳,获得10
13秒前
哭泣映易发布了新的文献求助10
13秒前
cheers发布了新的文献求助10
13秒前
eay完成签到,获得积分20
14秒前
14秒前
绘海完成签到,获得积分10
15秒前
枫桥完成签到 ,获得积分10
16秒前
酷波er的应助被王政采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Monte Cassino in the Middle Ages Volume I 310
JUSTIFICATION OF SMALL-SCALE MODELS: AN INDUSTRY PERSPECTIVE 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8156113
求助须知:如何正确求助?哪些是违规求助? 9552375
关于积分的说明 21709417
捐赠科研通 7745230
什么是DOI,文献DOI怎么找? 3426391
关于科研通互助平台的介绍 2551314
邀请新用户注册赠送积分活动 2470141